Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women

    August 2019 in “ BioMed Research International ”
    Siriluk Tantanavipas, Orawin Vallibhakara, Abhasnee Sobhonslidsuk, Sith Phongkitkarun, Sakda Arj-Ong Vallibhakara, Kwannapa Promson, Areepan Sophonsritsuk
    Image of study
    TLDR Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.
    The study conducted in 2019 involved 63 women, 42 with Polycystic ovary syndrome (PCOS) and 21 healthy women, aged between 20 to 40 years. The research aimed to identify predictive factors of nonalcoholic fatty liver disease (NAFLD) in these women. The study found that abdominal obesity, measured by a waist circumference greater than 80 cm, was the only significant predictor of NAFLD in both groups. Other factors such as BMI, fasting blood sugar, insulin resistance, and metabolic syndrome were initially associated with NAFLD, but only waist circumference remained significantly associated after multivariate logistic regression. The study also found that transient elastography-based controlled attenuation parameter (TE-CAP) values significantly correlated with steatosis stage as assessed by ultrasonography. The study concluded that abdominal obesity, rather than the presence of PCOS, was the independently associated factor for NAFLD.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results